lamivudinehttp://www.unboundmedicine.com/medline/ebm/research/lamivudineUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.Mortality and drug exposure in a 5-year cohort of patients with chronic liver disease.http://www.unboundmedicine.com/medline/ebm/record/19924579/full_citation/Mortality_and_drug_exposure_in_a_5_year_cohort_of_patients_with_chronic_liver_disease_Hug BL, Lipsitz SR, Seger DL, et al. 
Mortality and drug exposure in a 5-year cohort of patients with chronic liver disease. [JOURNAL ARTICLE]
Swiss Med Wkly 2009 Nov 19.
Abstract | Full CitationTreatment of HIV infection: Swedish recommendations 2009.http://www.unboundmedicine.com/medline/ebm/record/19922061/full_citation/Treatment_of_HIV_infection:_Swedish_recommendations_2009_Josephson F, Albert J, Flamholc L, et al. 
Treatment of HIV infection: Swedish recommendations 2009. [JOURNAL ARTICLE]
Scand J Infect Dis 2009; 41(11-12):788-807.
Abstract | Full Citation | Find Related Articles Progress in basic and clinical research on HIV resistance: report on the XVIII International HIV Drug Resistance Workshop.http://www.unboundmedicine.com/medline/ebm/record/19918107/full_citation/Progress_in_basic_and_clinical_research_on_HIV_resistance:_report_on_the_XVIII_International_HIV_Drug_Resistance_Workshop_Mascolini M, Boucher CA, Mellors JW, et al. 
Progress in basic and clinical research on HIV resistance: report on the XVIII International HIV Drug Resistance Workshop. [Journal Article]
Antivir Ther 2009; 14(7):1015-37.
Abstract | Full CitationEvolution of hepatitis B virus mutation during entecavir rescue therapy in patients with antiviral resistance to lamivudine and adefovir.http://www.unboundmedicine.com/medline/ebm/record/19918102/full_citation/Evolution_of_hepatitis_B_virus_mutation_during_entecavir_rescue_therapy_in_patients_with_antiviral_resistance_to_lamivudine_and_adefovir_Choe WH, Hong SP, Kim BK, et al. 
Evolution of hepatitis B virus mutation during entecavir rescue therapy in patients with antiviral resistance to lamivudine and adefovir. [Journal Article]
Antivir Ther 2009; 14(7):985-93.
Abstract | Full CitationPostpartum antiretroviral drug resistance in HIV-1-infected women receiving pregnancy-limited antiretroviral therapy.http://www.unboundmedicine.com/medline/ebm/record/19915448/full_citation/Postpartum_antiretroviral_drug_resistance_in_HIV_1_infected_women_receiving_pregnancy_limited_antiretroviral_therapy_Paredes R, Cheng I, Kuritzkes DR, et al. 
Postpartum antiretroviral drug resistance in HIV-1-infected women receiving pregnancy-limited antiretroviral therapy. [JOURNAL ARTICLE]
AIDS 2009 Nov 12.
Abstract | Full Citation | Publisher Full Text | Find Related Articles [A clinical study of adefovir dipivoxil treatment for chronic hepatitis patients with cirrhosis in their decompensation period.]http://www.unboundmedicine.com/medline/ebm/record/19912686/full_citation/[A_clinical_study_of_adefovir_dipivoxil_treatment_for_chronic_hepatitis_patients_with_cirrhosis_in_their_decompensation_period_]Yang Q, Gong ZJ, Hu DF 
[A clinical study of adefovir dipivoxil treatment for chronic hepatitis patients with cirrhosis in their decompensation period.] [English Abstract, Journal Article]
Zhonghua Gan Zang Bing Za Zhi 2009 Jul; 17(7):515-9.
Abstract | Full Citation | Find Related Articles [Lamivudine, interferon-alpha and oxymatrine treatment for the surviving hepatic failure patients with hepatitis B.]http://www.unboundmedicine.com/medline/ebm/record/19912684/full_citation/[Lamivudine_interferon_alpha_and_oxymatrine_treatment_for_the_surviving_hepatic_failure_patients_with_hepatitis_B_]Chen CX, Liu B, Ma Y, et al. 
[Lamivudine, interferon-alpha and oxymatrine treatment for the surviving hepatic failure patients with hepatitis B.] [English Abstract, Journal Article]
Zhonghua Gan Zang Bing Za Zhi 2009 Jul; 17(7):505-8.
Abstract | Full CitationViremia, Resuppression, and Time to Resistance in Human Immunodeficiency Virus (HIV) Subtype C during First-Line Antiretroviral Therapy in South Africa.http://www.unboundmedicine.com/medline/ebm/record/19911963/full_citation/Viremia_Resuppression_and_Time_to_Resistance_in_Human_Immunodeficiency_Virus__HIV__Subtype_C_during_First_Line_Antiretroviral_Therapy_in_South_Africa_Hoffmann CJ, Charalambous S, Sim J, et al. 
Viremia, Resuppression, and Time to Resistance in Human Immunodeficiency Virus (HIV) Subtype C during First-Line Antiretroviral Therapy in South Africa. [JOURNAL ARTICLE]
Clin Infect Dis 2009 Nov 13.
Abstract | Full Citation | Find Related Articles Gateways to clinical trials.http://www.unboundmedicine.com/medline/ebm/record/19907722/full_citation/Gateways_to_clinical_trials_Tomillero A, Moral MA 
Gateways to clinical trials. [Journal Article]
Methods Find Exp Clin Pharmacol 2009 Sep; 31(7):463-93.
Abstract | Full CitationRisk of Extended Viral Resistance in Human Immunodeficiency Virus-1-Infected Mozambican Children After First-Line Treatment Failure.http://www.unboundmedicine.com/medline/ebm/record/19907359/full_citation/Risk_of_Extended_Viral_Resistance_in_Human_Immunodeficiency_Virus_1_Infected_Mozambican_Children_After_First_Line_Treatment_Failure_Vaz P, Chaix ML, Jani I, et al. 
Risk of Extended Viral Resistance in Human Immunodeficiency Virus-1-Infected Mozambican Children After First-Line Treatment Failure. [JOURNAL ARTICLE]
Pediatr Infect Dis J 2009 Nov 10.
Abstract | Full Citation